Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
PERCEPTIVE ADVISORS LLC has filed 7 SEC Form 4 filings across 5 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $10.30M. Lifetime open-market sales: $9.30M. Historical track record: 1/5 stars across 6 tracked purchases.
| Role | Insider |
|---|---|
| Notability | 30/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
|---|---|
| Total purchases tracked | 6 |
| Purchases with forward-return data | 6 |
| 30-day win rate | 3333% |
| 90-day win rate | 3333% |
| Avg 5-day return | -416.43% |
| Avg 30-day return | -2545.57% |
| Avg 90-day return | -517.26% |
| Best 30-day return | +1229.51% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | KARD | Kardigan, Inc. | A — Grant or award | 20.7K | $0.00 | |
| 2026-04-24 | MGTX | MeiraGTx Holdings plc | A — Grant or award | 555.6K | $9.00 | $5.00M |
| 2026-01-02 | MGTX | MeiraGTx Holdings plc | D — Derivative transaction | 2.30M | $7.91 | $18.19M |
| 2025-12-23 | LONA | LeonaBio, Inc. | A — Grant or award | 329.8K | $6.35 | $2.09M |
| 2025-12-23 | LONA | LeonaBio, Inc. | A — Grant or award | 989.3K | $6.35 | $6.28M |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 3.2K | $3.90 | $13K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 28.6K | $3.90 | $112K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 883 | $4.06 | $4K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 7.9K | $4.06 | $32K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 537 | $4.31 | $2K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 4.8K | $4.31 | $21K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 3.2K | $3.90 | $13K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 28.6K | $3.90 | $112K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 883 | $4.06 | $4K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 7.9K | $4.06 | $32K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 537 | $4.31 | $2K |
| 2025-11-13 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 4.8K | $4.31 | $21K |
| 2025-11-10 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 1.9K | $4.54 | $8K |
| 2025-11-10 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 16.6K | $4.54 | $76K |
| 2025-11-10 | LYRA | Lyra Therapeutics, Inc. | S — Open-market sale | 2.0K | $4.75 | $9K |
PERCEPTIVE ADVISORS LLC is a corporate insider — currently tracked as Insider of Kardigan, Inc. (KARD). InsiderAlpha tracks every SEC Form 4 filing in real time.
7 primary Form 4 filings in the last 90 days, covering 5 companies.
Recorded transactions: 6 open-market purchases ($10.30M) and 24 open-market sales ($9.30M) across all tracked filings.
Across 6 tracked purchases, PERCEPTIVE ADVISORS LLC averaged -2545.6% avg 30-day return with a 3333% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PERCEPTIVE ADVISORS LLC profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.